1411 related articles for article (PubMed ID: 18706410)
1. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
3. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
4. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
5. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
6. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
7. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and opioid activity of new fentanyl analogs.
Girón R; Abalo R; Goicoechea C; Martín MI; Callado LF; Cano C; Goya P; Jagerovic N
Life Sci; 2002 Jul; 71(9):1023-34. PubMed ID: 12088762
[TBL] [Abstract][Full Text] [Related]
9. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
Al-Khrasani M; Lackó E; Riba P; Király K; Sobor M; Timár J; Mousa S; Schäfer M; Fürst S
Brain Res Bull; 2012 Feb; 87(2-3):238-43. PubMed ID: 22079588
[TBL] [Abstract][Full Text] [Related]
10. Effects of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on the antinociceptive activity of pethidine administered at the peripheral and supraspinal level.
Fu CY; Tang XL; Yang Q; Chen Q; Wang R
Behav Brain Res; 2007 Nov; 184(1):39-46. PubMed ID: 17675256
[TBL] [Abstract][Full Text] [Related]
11. [Opioid dependence and tolerance in the guinea-pig ileum in vitro].
Chen JQ; Jin WQ; Chi ZQ
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):488-91. PubMed ID: 2130610
[TBL] [Abstract][Full Text] [Related]
12. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological analysis of paregoric elixir and its constituents: in vitro and in vivo studies.
Andrade EL; Ferreira J; Santos AR; Calixto JB
J Ethnopharmacol; 2007 Nov; 114(2):218-26. PubMed ID: 17869462
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
15. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
Mundey MK; Mason R; Wilson VG
Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
[TBL] [Abstract][Full Text] [Related]
16. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
19. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
20. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]